Global Rapid Influenza Diagnostic Test Market

Rapid Influenza Diagnostic Test Comprehensive Study by Type (Digital RIDTs, Conventional RIDT), Application (Hospitals & Clinics, Laboratories, Other), Test (Point-of-Care test, Nucleic Acid Test, Immunofluorescence Assays, Others) Players and Region - Global Market Outlook to 2026

Rapid Influenza Diagnostic Test Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 9.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
A rapid influenza diagnostic test helps to determine whether a person has a current influenza infection by detecting the influenza viral nucleoprotein antigen. Some of the major advantages of rapid influenza diagnostic tests are RIDTs are approved for office or bedside use, produce a quick result in 15 minutes or less, simple to perform, among others. There are various factors which influence the accuracy of RIDTs such as clinical signs and symptoms consistent with influenza, the prevalence of influenza activity in the population tested, the accuracy of the test compared to a reference test, among others.
According to AMA, the market for Rapid Influenza Diagnostic Test is expected to register a CAGR of 9.1% during the forecast period to 2026. This growth is primarily driven by Growing Usage of RFID in Various Application, High Invested Research as well as Development Regarding Rapid Influenza Diagnostic Tests and Increasing Number of Influenza Patients across the world.

Globally, a noticeable market trend is evident Technology Advancement in Rapid Influenza Diagnostic Test. The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (United States), Quidel Corporation (United States), Becton, Dickinson and Company (United States), DiaSorin (Italy), SA Scientific Ltd. (United States), Meridian Bioscience, Inc. (United States), Analytik Jena AG (Germany) and Luminex Corporation (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In June 2019, the Becton, Dickinson, and Company have started a new partnership with the United States Government through the United States Agency for International Development. In addition, it supports Indonesia in removing tuberculosis. Hence, this partnership would strengthen its position in the rapid influenza diagnostic test.

Market Drivers
  • Growing Usage of RFID in Various Application
  • High Invested Research as well as Development Regarding Rapid Influenza Diagnostic Tests
  • Increasing Number of Influenza Patients across the world

Market Trend
  • Technology Advancement in Rapid Influenza Diagnostic Test

Restraints
  • Issue related to Sensitivity of RIDTs to Detect Influenza B viral Antigens is lower than Detection of Influenza a Viral Antigens

Opportunities
Growing Demand from Emerging Market such as China, India, Brazil, among others
Challenges
Problem-related to Sub-Optimal Test Sensitivity and False Negative Results are Common

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Rapid Influenza Diagnostic Test Study Sheds Light on
— The Rapid Influenza Diagnostic Test Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Rapid Influenza Diagnostic Test industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Rapid Influenza Diagnostic Test industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Digital RIDTs
  • Conventional RIDT
By Application
  • Hospitals & Clinics
  • Laboratories
  • Other
By Test
  • Point-of-Care test
  • Nucleic Acid Test
  • Immunofluorescence Assays
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Usage of RFID in Various Application
      • 3.2.2. High Invested Research as well as Development Regarding Rapid Influenza Diagnostic Tests
      • 3.2.3. Increasing Number of Influenza Patients across the world
    • 3.3. Market Challenges
      • 3.3.1. Problem-related to Sub-Optimal Test Sensitivity and False Negative Results are Common
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Rapid Influenza Diagnostic Test
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rapid Influenza Diagnostic Test, by Type, Application, Test and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Rapid Influenza Diagnostic Test (Value)
      • 5.2.1. Global Rapid Influenza Diagnostic Test by: Type (Value)
        • 5.2.1.1. Digital RIDTs
        • 5.2.1.2. Conventional RIDT
      • 5.2.2. Global Rapid Influenza Diagnostic Test by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Laboratories
        • 5.2.2.3. Other
      • 5.2.3. Global Rapid Influenza Diagnostic Test by: Test (Value)
        • 5.2.3.1. Point-of-Care test
        • 5.2.3.2. Nucleic Acid Test
        • 5.2.3.3. Immunofluorescence Assays
        • 5.2.3.4. Others
      • 5.2.4. Global Rapid Influenza Diagnostic Test Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Rapid Influenza Diagnostic Test (Volume)
      • 5.3.1. Global Rapid Influenza Diagnostic Test by: Type (Volume)
        • 5.3.1.1. Digital RIDTs
        • 5.3.1.2. Conventional RIDT
      • 5.3.2. Global Rapid Influenza Diagnostic Test by: Application (Volume)
        • 5.3.2.1. Hospitals & Clinics
        • 5.3.2.2. Laboratories
        • 5.3.2.3. Other
      • 5.3.3. Global Rapid Influenza Diagnostic Test by: Test (Volume)
        • 5.3.3.1. Point-of-Care test
        • 5.3.3.2. Nucleic Acid Test
        • 5.3.3.3. Immunofluorescence Assays
        • 5.3.3.4. Others
      • 5.3.4. Global Rapid Influenza Diagnostic Test Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Rapid Influenza Diagnostic Test (Price)
      • 5.4.1. Global Rapid Influenza Diagnostic Test by: Type (Price)
  • 6. Rapid Influenza Diagnostic Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Quidel Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DiaSorin (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SA Scientific Ltd. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Meridian Bioscience, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Analytik Jena AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Luminex Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Rapid Influenza Diagnostic Test Sale, by Type, Application, Test and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Rapid Influenza Diagnostic Test (Value)
      • 7.2.1. Global Rapid Influenza Diagnostic Test by: Type (Value)
        • 7.2.1.1. Digital RIDTs
        • 7.2.1.2. Conventional RIDT
      • 7.2.2. Global Rapid Influenza Diagnostic Test by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Laboratories
        • 7.2.2.3. Other
      • 7.2.3. Global Rapid Influenza Diagnostic Test by: Test (Value)
        • 7.2.3.1. Point-of-Care test
        • 7.2.3.2. Nucleic Acid Test
        • 7.2.3.3. Immunofluorescence Assays
        • 7.2.3.4. Others
      • 7.2.4. Global Rapid Influenza Diagnostic Test Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Rapid Influenza Diagnostic Test (Volume)
      • 7.3.1. Global Rapid Influenza Diagnostic Test by: Type (Volume)
        • 7.3.1.1. Digital RIDTs
        • 7.3.1.2. Conventional RIDT
      • 7.3.2. Global Rapid Influenza Diagnostic Test by: Application (Volume)
        • 7.3.2.1. Hospitals & Clinics
        • 7.3.2.2. Laboratories
        • 7.3.2.3. Other
      • 7.3.3. Global Rapid Influenza Diagnostic Test by: Test (Volume)
        • 7.3.3.1. Point-of-Care test
        • 7.3.3.2. Nucleic Acid Test
        • 7.3.3.3. Immunofluorescence Assays
        • 7.3.3.4. Others
      • 7.3.4. Global Rapid Influenza Diagnostic Test Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Rapid Influenza Diagnostic Test (Price)
      • 7.4.1. Global Rapid Influenza Diagnostic Test by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rapid Influenza Diagnostic Test: by Type(USD Million)
  • Table 2. Rapid Influenza Diagnostic Test Digital RIDTs , by Region USD Million (2015-2020)
  • Table 3. Rapid Influenza Diagnostic Test Conventional RIDT , by Region USD Million (2015-2020)
  • Table 4. Rapid Influenza Diagnostic Test: by Application(USD Million)
  • Table 5. Rapid Influenza Diagnostic Test Hospitals & Clinics , by Region USD Million (2015-2020)
  • Table 6. Rapid Influenza Diagnostic Test Laboratories , by Region USD Million (2015-2020)
  • Table 7. Rapid Influenza Diagnostic Test Other , by Region USD Million (2015-2020)
  • Table 8. Rapid Influenza Diagnostic Test: by Test(USD Million)
  • Table 9. Rapid Influenza Diagnostic Test Point-of-Care test , by Region USD Million (2015-2020)
  • Table 10. Rapid Influenza Diagnostic Test Nucleic Acid Test , by Region USD Million (2015-2020)
  • Table 11. Rapid Influenza Diagnostic Test Immunofluorescence Assays , by Region USD Million (2015-2020)
  • Table 12. Rapid Influenza Diagnostic Test Others , by Region USD Million (2015-2020)
  • Table 13. South America Rapid Influenza Diagnostic Test, by Country USD Million (2015-2020)
  • Table 14. South America Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 15. South America Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 16. South America Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 17. Brazil Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 18. Brazil Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 19. Brazil Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 20. Argentina Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 21. Argentina Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 22. Argentina Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 23. Rest of South America Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 25. Rest of South America Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 26. Asia Pacific Rapid Influenza Diagnostic Test, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 29. Asia Pacific Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 30. China Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 31. China Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 32. China Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 33. Japan Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 34. Japan Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 35. Japan Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 36. India Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 37. India Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 38. India Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 39. South Korea Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 40. South Korea Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 41. South Korea Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 42. Taiwan Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 43. Taiwan Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 44. Taiwan Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 45. Australia Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 46. Australia Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 47. Australia Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 51. Europe Rapid Influenza Diagnostic Test, by Country USD Million (2015-2020)
  • Table 52. Europe Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 53. Europe Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 54. Europe Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 55. Germany Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 56. Germany Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 57. Germany Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 58. France Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 59. France Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 60. France Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 61. Italy Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 62. Italy Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 63. Italy Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 64. United Kingdom Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 66. United Kingdom Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 67. Netherlands Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 68. Netherlands Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 69. Netherlands Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 70. Rest of Europe Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 72. Rest of Europe Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 73. MEA Rapid Influenza Diagnostic Test, by Country USD Million (2015-2020)
  • Table 74. MEA Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 75. MEA Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 76. MEA Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 77. Middle East Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 78. Middle East Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 79. Middle East Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 80. Africa Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 81. Africa Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 82. Africa Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 83. North America Rapid Influenza Diagnostic Test, by Country USD Million (2015-2020)
  • Table 84. North America Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 85. North America Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 86. North America Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 87. United States Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 88. United States Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 89. United States Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 90. Canada Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 91. Canada Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 92. Canada Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 93. Mexico Rapid Influenza Diagnostic Test, by Type USD Million (2015-2020)
  • Table 94. Mexico Rapid Influenza Diagnostic Test, by Application USD Million (2015-2020)
  • Table 95. Mexico Rapid Influenza Diagnostic Test, by Test USD Million (2015-2020)
  • Table 96. Rapid Influenza Diagnostic Test Sales: by Type(M Tons)
  • Table 97. Rapid Influenza Diagnostic Test Sales Digital RIDTs , by Region M Tons (2015-2020)
  • Table 98. Rapid Influenza Diagnostic Test Sales Conventional RIDT , by Region M Tons (2015-2020)
  • Table 99. Rapid Influenza Diagnostic Test Sales: by Application(M Tons)
  • Table 100. Rapid Influenza Diagnostic Test Sales Hospitals & Clinics , by Region M Tons (2015-2020)
  • Table 101. Rapid Influenza Diagnostic Test Sales Laboratories , by Region M Tons (2015-2020)
  • Table 102. Rapid Influenza Diagnostic Test Sales Other , by Region M Tons (2015-2020)
  • Table 103. Rapid Influenza Diagnostic Test Sales: by Test(M Tons)
  • Table 104. Rapid Influenza Diagnostic Test Sales Point-of-Care test , by Region M Tons (2015-2020)
  • Table 105. Rapid Influenza Diagnostic Test Sales Nucleic Acid Test , by Region M Tons (2015-2020)
  • Table 106. Rapid Influenza Diagnostic Test Sales Immunofluorescence Assays , by Region M Tons (2015-2020)
  • Table 107. Rapid Influenza Diagnostic Test Sales Others , by Region M Tons (2015-2020)
  • Table 108. South America Rapid Influenza Diagnostic Test Sales, by Country M Tons (2015-2020)
  • Table 109. South America Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 110. South America Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 111. South America Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 112. Brazil Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 113. Brazil Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 114. Brazil Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 115. Argentina Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 116. Argentina Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 117. Argentina Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 118. Rest of South America Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 119. Rest of South America Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 120. Rest of South America Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 121. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Country M Tons (2015-2020)
  • Table 122. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 123. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 124. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 125. China Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 126. China Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 127. China Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 128. Japan Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 129. Japan Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 130. Japan Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 131. India Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 132. India Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 133. India Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 134. South Korea Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 135. South Korea Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 136. South Korea Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 137. Taiwan Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 138. Taiwan Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 139. Taiwan Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 140. Australia Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 141. Australia Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 142. Australia Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 143. Rest of Asia-Pacific Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 144. Rest of Asia-Pacific Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 145. Rest of Asia-Pacific Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 146. Europe Rapid Influenza Diagnostic Test Sales, by Country M Tons (2015-2020)
  • Table 147. Europe Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 148. Europe Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 149. Europe Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 150. Germany Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 151. Germany Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 152. Germany Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 153. France Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 154. France Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 155. France Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 156. Italy Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 157. Italy Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 158. Italy Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 159. United Kingdom Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 160. United Kingdom Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 161. United Kingdom Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 162. Netherlands Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 163. Netherlands Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 164. Netherlands Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 165. Rest of Europe Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 166. Rest of Europe Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 167. Rest of Europe Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 168. MEA Rapid Influenza Diagnostic Test Sales, by Country M Tons (2015-2020)
  • Table 169. MEA Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 170. MEA Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 171. MEA Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 172. Middle East Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 173. Middle East Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 174. Middle East Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 175. Africa Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 176. Africa Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 177. Africa Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 178. North America Rapid Influenza Diagnostic Test Sales, by Country M Tons (2015-2020)
  • Table 179. North America Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 180. North America Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 181. North America Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 182. United States Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 183. United States Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 184. United States Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 185. Canada Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 186. Canada Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 187. Canada Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 188. Mexico Rapid Influenza Diagnostic Test Sales, by Type M Tons (2015-2020)
  • Table 189. Mexico Rapid Influenza Diagnostic Test Sales, by Application M Tons (2015-2020)
  • Table 190. Mexico Rapid Influenza Diagnostic Test Sales, by Test M Tons (2015-2020)
  • Table 191. Rapid Influenza Diagnostic Test: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Rapid Influenza Diagnostic Test: by Type(USD Million)
  • Table 203. Rapid Influenza Diagnostic Test Digital RIDTs , by Region USD Million (2021-2026)
  • Table 204. Rapid Influenza Diagnostic Test Conventional RIDT , by Region USD Million (2021-2026)
  • Table 205. Rapid Influenza Diagnostic Test: by Application(USD Million)
  • Table 206. Rapid Influenza Diagnostic Test Hospitals & Clinics , by Region USD Million (2021-2026)
  • Table 207. Rapid Influenza Diagnostic Test Laboratories , by Region USD Million (2021-2026)
  • Table 208. Rapid Influenza Diagnostic Test Other , by Region USD Million (2021-2026)
  • Table 209. Rapid Influenza Diagnostic Test: by Test(USD Million)
  • Table 210. Rapid Influenza Diagnostic Test Point-of-Care test , by Region USD Million (2021-2026)
  • Table 211. Rapid Influenza Diagnostic Test Nucleic Acid Test , by Region USD Million (2021-2026)
  • Table 212. Rapid Influenza Diagnostic Test Immunofluorescence Assays , by Region USD Million (2021-2026)
  • Table 213. Rapid Influenza Diagnostic Test Others , by Region USD Million (2021-2026)
  • Table 214. South America Rapid Influenza Diagnostic Test, by Country USD Million (2021-2026)
  • Table 215. South America Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 216. South America Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 217. South America Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 218. Brazil Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 219. Brazil Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 220. Brazil Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 221. Argentina Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 222. Argentina Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 223. Argentina Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 224. Rest of South America Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 225. Rest of South America Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 226. Rest of South America Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 227. Asia Pacific Rapid Influenza Diagnostic Test, by Country USD Million (2021-2026)
  • Table 228. Asia Pacific Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 229. Asia Pacific Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 230. Asia Pacific Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 231. China Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 232. China Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 233. China Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 234. Japan Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 235. Japan Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 236. Japan Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 237. India Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 238. India Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 239. India Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 240. South Korea Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 241. South Korea Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 242. South Korea Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 243. Taiwan Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 244. Taiwan Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 245. Taiwan Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 246. Australia Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 247. Australia Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 248. Australia Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 250. Rest of Asia-Pacific Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 251. Rest of Asia-Pacific Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 252. Europe Rapid Influenza Diagnostic Test, by Country USD Million (2021-2026)
  • Table 253. Europe Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 254. Europe Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 255. Europe Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 256. Germany Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 257. Germany Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 258. Germany Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 259. France Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 260. France Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 261. France Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 262. Italy Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 263. Italy Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 264. Italy Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 265. United Kingdom Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 266. United Kingdom Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 267. United Kingdom Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 268. Netherlands Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 269. Netherlands Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 270. Netherlands Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 271. Rest of Europe Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 272. Rest of Europe Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 273. Rest of Europe Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 274. MEA Rapid Influenza Diagnostic Test, by Country USD Million (2021-2026)
  • Table 275. MEA Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 276. MEA Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 277. MEA Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 278. Middle East Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 279. Middle East Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 280. Middle East Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 281. Africa Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 282. Africa Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 283. Africa Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 284. North America Rapid Influenza Diagnostic Test, by Country USD Million (2021-2026)
  • Table 285. North America Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 286. North America Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 287. North America Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 288. United States Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 289. United States Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 290. United States Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 291. Canada Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 292. Canada Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 293. Canada Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 294. Mexico Rapid Influenza Diagnostic Test, by Type USD Million (2021-2026)
  • Table 295. Mexico Rapid Influenza Diagnostic Test, by Application USD Million (2021-2026)
  • Table 296. Mexico Rapid Influenza Diagnostic Test, by Test USD Million (2021-2026)
  • Table 297. Rapid Influenza Diagnostic Test Sales: by Type(M Tons)
  • Table 298. Rapid Influenza Diagnostic Test Sales Digital RIDTs , by Region M Tons (2021-2026)
  • Table 299. Rapid Influenza Diagnostic Test Sales Conventional RIDT , by Region M Tons (2021-2026)
  • Table 300. Rapid Influenza Diagnostic Test Sales: by Application(M Tons)
  • Table 301. Rapid Influenza Diagnostic Test Sales Hospitals & Clinics , by Region M Tons (2021-2026)
  • Table 302. Rapid Influenza Diagnostic Test Sales Laboratories , by Region M Tons (2021-2026)
  • Table 303. Rapid Influenza Diagnostic Test Sales Other , by Region M Tons (2021-2026)
  • Table 304. Rapid Influenza Diagnostic Test Sales: by Test(M Tons)
  • Table 305. Rapid Influenza Diagnostic Test Sales Point-of-Care test , by Region M Tons (2021-2026)
  • Table 306. Rapid Influenza Diagnostic Test Sales Nucleic Acid Test , by Region M Tons (2021-2026)
  • Table 307. Rapid Influenza Diagnostic Test Sales Immunofluorescence Assays , by Region M Tons (2021-2026)
  • Table 308. Rapid Influenza Diagnostic Test Sales Others , by Region M Tons (2021-2026)
  • Table 309. South America Rapid Influenza Diagnostic Test Sales, by Country M Tons (2021-2026)
  • Table 310. South America Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 311. South America Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 312. South America Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 313. Brazil Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 314. Brazil Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 315. Brazil Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 316. Argentina Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 317. Argentina Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 318. Argentina Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 319. Rest of South America Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 320. Rest of South America Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 321. Rest of South America Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 322. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Country M Tons (2021-2026)
  • Table 323. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 324. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 325. Asia Pacific Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 326. China Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 327. China Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 328. China Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 329. Japan Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 330. Japan Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 331. Japan Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 332. India Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 333. India Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 334. India Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 335. South Korea Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 336. South Korea Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 337. South Korea Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 338. Taiwan Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 339. Taiwan Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 340. Taiwan Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 341. Australia Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 342. Australia Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 343. Australia Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 344. Rest of Asia-Pacific Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 345. Rest of Asia-Pacific Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 346. Rest of Asia-Pacific Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 347. Europe Rapid Influenza Diagnostic Test Sales, by Country M Tons (2021-2026)
  • Table 348. Europe Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 349. Europe Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 350. Europe Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 351. Germany Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 352. Germany Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 353. Germany Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 354. France Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 355. France Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 356. France Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 357. Italy Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 358. Italy Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 359. Italy Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 360. United Kingdom Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 361. United Kingdom Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 362. United Kingdom Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 363. Netherlands Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 364. Netherlands Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 365. Netherlands Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 366. Rest of Europe Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 367. Rest of Europe Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 368. Rest of Europe Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 369. MEA Rapid Influenza Diagnostic Test Sales, by Country M Tons (2021-2026)
  • Table 370. MEA Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 371. MEA Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 372. MEA Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 373. Middle East Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 374. Middle East Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 375. Middle East Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 376. Africa Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 377. Africa Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 378. Africa Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 379. North America Rapid Influenza Diagnostic Test Sales, by Country M Tons (2021-2026)
  • Table 380. North America Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 381. North America Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 382. North America Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 383. United States Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 384. United States Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 385. United States Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 386. Canada Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 387. Canada Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 388. Canada Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 389. Mexico Rapid Influenza Diagnostic Test Sales, by Type M Tons (2021-2026)
  • Table 390. Mexico Rapid Influenza Diagnostic Test Sales, by Application M Tons (2021-2026)
  • Table 391. Mexico Rapid Influenza Diagnostic Test Sales, by Test M Tons (2021-2026)
  • Table 392. Rapid Influenza Diagnostic Test: by Type(USD/Units)
  • Table 393. Research Programs/Design for This Report
  • Table 394. Key Data Information from Secondary Sources
  • Table 395. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rapid Influenza Diagnostic Test: by Type USD Million (2015-2020)
  • Figure 5. Global Rapid Influenza Diagnostic Test: by Application USD Million (2015-2020)
  • Figure 6. Global Rapid Influenza Diagnostic Test: by Test USD Million (2015-2020)
  • Figure 7. South America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 8. Asia Pacific Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 9. Europe Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 10. MEA Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 11. North America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 12. Global Rapid Influenza Diagnostic Test: by Type M Tons (2015-2020)
  • Figure 13. Global Rapid Influenza Diagnostic Test: by Application M Tons (2015-2020)
  • Figure 14. Global Rapid Influenza Diagnostic Test: by Test M Tons (2015-2020)
  • Figure 15. South America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 16. Asia Pacific Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 17. Europe Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 18. MEA Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 19. North America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 20. Global Rapid Influenza Diagnostic Test: by Type USD/Units (2015-2020)
  • Figure 21. Global Rapid Influenza Diagnostic Test share by Players 2020 (%)
  • Figure 22. Global Rapid Influenza Diagnostic Test share by Players (Top 3) 2020(%)
  • Figure 23. Global Rapid Influenza Diagnostic Test share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 27. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2020
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 31. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Quidel Corporation (United States) Revenue: by Geography 2020
  • Figure 33. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 34. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 35. DiaSorin (Italy) Revenue, Net Income and Gross profit
  • Figure 36. DiaSorin (Italy) Revenue: by Geography 2020
  • Figure 37. SA Scientific Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 38. SA Scientific Ltd. (United States) Revenue: by Geography 2020
  • Figure 39. Meridian Bioscience, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Meridian Bioscience, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Analytik Jena AG (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Analytik Jena AG (Germany) Revenue: by Geography 2020
  • Figure 43. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Luminex Corporation (United States) Revenue: by Geography 2020
  • Figure 45. Global Rapid Influenza Diagnostic Test: by Type USD Million (2021-2026)
  • Figure 46. Global Rapid Influenza Diagnostic Test: by Application USD Million (2021-2026)
  • Figure 47. Global Rapid Influenza Diagnostic Test: by Test USD Million (2021-2026)
  • Figure 48. South America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 49. Asia Pacific Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 50. Europe Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 51. MEA Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 52. North America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 53. Global Rapid Influenza Diagnostic Test: by Type M Tons (2021-2026)
  • Figure 54. Global Rapid Influenza Diagnostic Test: by Application M Tons (2021-2026)
  • Figure 55. Global Rapid Influenza Diagnostic Test: by Test M Tons (2021-2026)
  • Figure 56. South America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 57. Asia Pacific Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 58. Europe Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 59. MEA Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 60. North America Rapid Influenza Diagnostic Test Share (%), by Country
  • Figure 61. Global Rapid Influenza Diagnostic Test: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Abbott Laboratories (United States)
  • Quidel Corporation (United States)
  • Becton, Dickinson and Company (United States)
  • DiaSorin (Italy)
  • SA Scientific Ltd. (United States)
  • Meridian Bioscience, Inc. (United States)
  • Analytik Jena AG (Germany)
  • Luminex Corporation (United States)
Select User Access Type

Key Highlights of Report


Dec 2021 248 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rapid Influenza Diagnostic Test Market Quantitative research analysis
Global Rapid Influenza Diagnostic Test Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Rapid Influenza Diagnostic Test market is expected to see a CAGR of 9.1% during projected year 2020 to 2026.
Top performing companies in the Global Rapid Influenza Diagnostic Test market are Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (United States), Quidel Corporation (United States), Becton, Dickinson and Company (United States), DiaSorin (Italy), SA Scientific Ltd. (United States), Meridian Bioscience, Inc. (United States), Analytik Jena AG (Germany) and Luminex Corporation (United States), to name a few.
North America is dominating the Rapid Influenza Diagnostic Test Market.

Know More About Global Rapid Influenza Diagnostic Test Market Report?

Have a Query? Click Here

Other Related Reports

Animal Biotechnology Comprehensive Study by Type (Animal Genomics, Animal Cloning, Genetic Engineering of Animals), Application (Preventive Care for Animals, Development of Animal Pharmaceuticals, Fo...
$ 3450
Bioproducts Comprehensive Study by Type (Conventional Bioproducts, Emerging Bioproducts), Application (Building Materials, Pulp and Paper, Forest Products, Medical, Energy, Chemical Industry, Agricul...
$ 3650
Stable Isotopes Labelled Compounds Comprehensive Study by Type (Carbon-13, Nitrogen-15, Oxygen-18, Deuterium, Other Isotopes), Application (Research {Biomedical Research, Pharmaceutical Research, Env...
$ 3750
Botanical Extracts Comprehensive Study by Type (Hydrosols, Alcohol Tinctures, CO2 extracts, Glycerites, Powdered Extracts, Others), Application (Food {Bakery & Confectionery, Sauces & Dressings}, Bev...
$ 3750
Cytology and HPV Testing Comprehensive Study by Type (Systems, Assay Kits, Services), Application (Cervical Cancer Screening Test, Head and Neck Cancer Screening Test, Molecular Diagnostics, Research...
$ 3650
Bare Metal Stents Comprehensive Study by Type (Balloon Catheter, Self-Expandable Metallic Stent, Balloon Expandable Stent), Application (Large Vessel, Small Vessel), End Users (Hospitals, Ambulatory ...
$ 3450